238.3 🩺 內科專科考前版

238.3.0.1 1⃣ Pre-Immunosuppression Screening for Strongyloides

  • Patients from endemic regions (Latin America, Africa, Caribbean, SE Asia, Appalachia, parts of Eastern Europe):
    • Stool O+P × 3
    • Serology (most sensitive)
    • PCR (emerging)
  • Empirical ivermectin if positive or strong clinical suspicion
  • Before corticosteroids, organ transplant, anti-TNF, chemotherapy
  • Reduces hyperinfection risk dramatically
  • 2 doses ivermectin 200 µg/kg, 2 weeks apart

238.3.0.2 2⃣ Strongyloides Hyperinfection Triggers

  • Corticosteroids (even oral dexamethasone for COVID-19) — dose-dependent
  • Organ transplant immunosuppression
  • HTLV-1 infection
  • Hematologic malignancy
  • Chemotherapy
  • Anti-TNF (rare but reported)
  • BMT
  • Don’t forget pre-screening even for “low-dose” corticosteroids in high-risk patients

238.3.0.3 3⃣ Hyperinfection Treatment

  • Ivermectin 200 µg/kg PO daily × 2 weeks (extended duration)
  • Add albendazole 400 mg PO bid × 2 weeks (combination)
  • Reduce immunosuppression if possible
  • Subcutaneous / rectal ivermectin if PO not tolerated (off-label, sometimes used)
  • Supportive: ICU + ventilator + IV antibiotics for gram-negative sepsis + dialysis

238.3.0.4 4⃣ Cutaneous Larva Migrans Differential

  • Strongyloides larva currens — serpiginous, intermittent, lower trunk/buttocks (from autoinfection)
  • Animal hookworm CLM — serpiginous, lower extremities/buttocks, beach exposure
  • Gnathostomiasis — migratory swellings (Asia, Latin America)
  • Loa loa migration (Africa)
  • Treatment: ivermectin or albendazole (both effective for most)

238.3.0.5 5⃣ Ascaris Intestinal Obstruction

  • Heavy burden pediatric
  • Surgical emergency
  • Often requires laparotomy + manual extraction
  • Treat all family members
  • Improve sanitation

238.3.0.6 6⃣ Biliary Ascariasis

  • Adult worm migrates into common bile duct
  • Cholangitis, pancreatitis
  • ERCP + extraction
  • Albendazole post-extraction
  • Endemic areas common

238.3.0.7 7⃣ MDA + STH Elimination Targets

  • WHO 2030: STH elimination as public health problem (< 2% moderate-heavy infection in target groups)
  • Albendazole / mebendazole annual / biannual
  • School + community-based
  • Combination with other antiparasitics
  • Major reductions achieved 2010s+

238.3.0.8 8⃣ 健保 / Taiwan

  • 公費 STH deworming (school-age children historically; now selective)
  • 健保 albendazole / mebendazole + ivermectin
  • 通報 (some STH)
  • Endemic + imported cases

238.3.0.9 9⃣ Anemia Workup + Hookworm

  • Unexplained iron deficiency anemia in patient with endemic exposure / from endemic area
  • Stool O+P for hookworm eggs
  • Empirical deworming if high suspicion
  • Iron supplementation + albendazole

238.3.0.10 10. Future

  • mRNA helminth vaccines (research)
  • New antiparasitics
  • Combination drugs (ivermectin + moxidectin)
  • Improved diagnostics (POC tests)